Schedule 13G ownership disclosure
Maze Therapeutics Inc
Common Stock · CUSIP: 578784100
Event date: 2025-03-31
- Filing-level shares
- 2,498,111
- Percent of class
- 5.7%
- JANUS HENDERSON GROUP PLC
Shares: 2,498,111 · Class: 5.7%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001274173-25-000124
- Form type
- SCHEDULE 13G
- Filer
- JANUS HENDERSON GROUP PLC
- CIK
- CIK 1274173
- Filed
- May 14, 2025
- Reporting period
- Mar 31, 2025
- Description
- Schedule 13G beneficial ownership